Evidence map›Paper›PMID 26589301›Full record

ArticleEuropean journal of nutrition2017

Zinc enhances the number of regulatory T cells in allergen-stimulated cells from atopic subjects.

Eva Rosenkranz, Ralf-Dieter Hilgers, Peter Uciechowski, Arnd Petersen, Birgit Plümäkers, Lothar Rink

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04983017 (Randomized, Double-Blinded, Placebo-Controlled Study With Immunotype Specific Dietary Supplements to Improve Inflammatory Age® by Edifice Health), which is not on this map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04983017 naterminatednot on this mapstarted 2021, after this paper: background citation

Randomized, Double-Blinded, Placebo-Controlled Study With Immunotype Specific Dietary Supplements to Improve Inflammatory Age® by Edifice Health

TypeinterventionalSponsorEdifice HealthRan2021 to 2022Enrolled781ConditionsChronic Inflammation, InflammagingArmsDietary supplement, Placebo
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. CaCell death discovery · 2024
    Article
  6. Review
  7. Review
  8. Review
  9. Protective role of zinc in the pathogenesis of respiratory diseases.European journal of clinical nutrition · 2023
    Review
  10. Review
  11. Ionic mitigation of CD4Scientific reports · 2022
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Advances of Zinc Signaling Studies in Prostate Cancer.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Eva RosenkranzInstitute of Immunology, Faculty of Medicine, University Hospital, RWTH Aachen University, Pauwelstr. 30, 52074, Aachen, Germany.
Ralf-Dieter HilgersInstitute of Medical Statistics, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
Peter UciechowskiInstitute of Immunology, Faculty of Medicine, University Hospital, RWTH Aachen University, Pauwelstr. 30, 52074, Aachen, Germany.
Arnd PetersenDivision of Clinical and Molecular Allergology, Research Center Borstel, Airway Research Center North (ARCN), Borstel, Germany.
Birgit PlümäkersInstitute of Immunology, Faculty of Medicine, University Hospital, RWTH Aachen University, Pauwelstr. 30, 52074, Aachen, Germany.
Lothar RinkInstitute of Immunology, Faculty of Medicine, University Hospital, RWTH Aachen University, Pauwelstr. 30, 52074, Aachen, Germany. LRink@UKAachen.de.
RWTH Aachen University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe trace element zinc is essential for immune function and its regulation. Since zinc deficiency and allergic hyperresponsive reactions are often accompanied, the influence of zinc on allergen-induced cell growth, CD4+ regulatory T (Treg) cell numbers and cytokine expression during allergic immune reactions was investigated.

methodsPeripheral blood mononuclear cells (PBMCs) from non-atopic and atopic subjects were treated with timothy grass allergen pre-incubated with or without zinc. Proliferation was determined by analyzing the incorporation of

resultsIncubation with 50 μM zinc sulfate (Zn50) enhances cytosolic zinc concentrations in CD3+ T cells. The data also reveal that the combination of Zn50 plus allergen significantly reduces PBMC proliferation of atopic subjects. Additionally, Zn50 plus allergen enhances Th1 cytokine responses shown by increased interferon (IFN)-γ/interleukin (IL)-10 ratios as well as enhanced tumor necrosis factor-α release. In response to allergen, zinc increases Treg cells and upregulates the mRNA expression of cytotoxic T-lymphocyte antigen-4 in atopic subjects. Interestingly, Zn50 alone leads to an increase of CD4+CD25high(hi)+ cells in atopic and non-atopic subjects.

conclusionsZinc may regulate unwanted hyperresponsive immune reactions by suppressing proliferation through a significant shift from IL-10 to the Th1 cytokine IFN-γ, and enhanced regulatory T cell numbers. Therefore, zinc supplementation may be a promising tool for the therapy of allergies, without negatively affecting the immune system.

Indexed as

AllergensCell ProliferationCells, CulturedHumansHypersensitivity, ImmediateInterferon-gammaInterleukin-10Leukocytes, MononuclearLymphocyte CountPhleumRNA, MessengerT-Lymphocytes, RegulatoryTumor Necrosis Factor-alphaZincAllergensIL10 protein, humanInterferon-gammaInterleukin-10RNA, MessengerTumor Necrosis Factor-alphaZincAllergyFoxp3Nutritional immunologyRegulatory T cellsTregZinc

Identifiers

PMID26589301
OpenAlexW2241884422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.